Literature DB >> 31356424

Standardized, Patient-specific, Postoperative Opioid Prescribing After Inpatient Orthopaedic Surgery.

Eric Y Chen1, Lauren Betancourt, Lulu Li, Emma Trucks, Andrew Marcantonio, Paul Tornetta.   

Abstract

BACKGROUND: Opioid-related mortality has increased over the past 2 decades, leading to the recognition of a nationwide opioid epidemic and prompting physicians to reexamine their opioid prescribing practices. At our institutions, we had no protocol for prescribing opioids upon discharge after inpatient orthopaedic surgery, resulting in inconsistent and potentially excessive prescribing. Here, we report the results of the implementation of a patient-specific protocol using an opioid taper calculator to standardize opioid prescribing at discharge after inpatient orthopaedic surgery.
METHODS: The opioid taper calculator is a tool that creates a patient-specific opioid taper based on each patient's 24-hour predischarge opioid utilization. We implemented this taper for patients discharged after inpatient orthopaedic surgery at our two institutions (Boston Medical Center and Lahey Hospital and Medical Center-Burlington Campus). We compared discharge opioid quantities between orthopaedic patients postimplementation and quantities prescribed preimplementation. We also compared discharge opioid quantities between orthopaedic and nonorthopaedic surgical services over the same time period.
RESULTS: Nine-months postimplementation, a patient-specific taper was used in 74% of eligible discharges, resulting in a 24% reduction in opioids prescribed at discharge, along with a 35% reduction in variance. Over the same time frame, a smaller reduction (9%) was seen in the opioids prescribed at discharge by nonorthopaedic services. The most notable reductions were seen after total joint arthroplasty and spinal fusions. Despite this reduction, most patients (65%) reported receiving sufficient opioids, and no substantial change was observed in 30-day postdischarge opioid prescription refills after versus before protocol implementation (1.58 versus 1.71 fills per discharge). DISCUSSION: Using the opioid taper calculator, a patient-specific taper can be successfully used to standardize opioid prescribing at discharge after inpatient orthopaedic surgery without a substantial risk of underprescription. LEVEL OF EVIDENCE: Level II.

Entities:  

Year:  2020        PMID: 31356424     DOI: 10.5435/JAAOS-D-19-00030

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  6 in total

Review 1.  Reducing New Persistent Opioid Use After Surgery: A Review of Interventions.

Authors:  Stacey Burns; Richard Urman; Rachel Pian; Oscar Jim Michael Coppes
Journal:  Curr Pain Headache Rep       Date:  2021-03-24

2.  Use of a Non-Pharmacological Pain Relief Kit to Reduce Opioid Use Following Orthopedic Surgery: A Prospective Randomized Study.

Authors:  Denis J O'Hara; Timothy F Tyler; Malachy P McHugh; Susan Y Kwiecien; Tyler Bergeron
Journal:  Int J Sports Phys Ther       Date:  2022-08-01

3.  Spica Casting of Pediatric Femur Fractures: The Pain Management Experience at One Institution.

Authors:  Kevin Williams; Noor Saeed; Stephanie Ihnow; Colleen Mangeot; Jaime Denning
Journal:  Cureus       Date:  2022-08-31

4.  Methadone Prescribing for Pain Management in Pennsylvania per the Prescription Drug Monitoring Program, 2016-2020.

Authors:  Jenna R Adalbert; Karan Varshney; Jeffrey Hom; Asif M Ilyas
Journal:  Cureus       Date:  2022-08-30

5.  Retrospective chart review of perioperative pain management of patients having surgery for closed ankle fractures using peripheral nerve blocks at a level one trauma center.

Authors:  Sara Mateen; Vishal Gandhi; Andrew J Meyr; Kwasi Y Kwaadu; Anish Sethi
Journal:  Pain Rep       Date:  2021-02-16

Review 6.  Strategies aimed at preventing long-term opioid use in trauma and orthopaedic surgery: a scoping review.

Authors:  C Côté; M Bérubé; L Moore; F Lauzier; L Tremblay; E Belzile; M-O Martel; G Pagé; Y Beaulieu; A M Pinard; K Perreault; C Sirois; S Grzelak; A F Turgeon
Journal:  BMC Musculoskelet Disord       Date:  2022-03-11       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.